Risk of SARS-CoV-2 reinfection during multiple Omicron variant waves in the UK general population

Jia Wei, Nicole Stoesser, Philippa C. Matthews, Tarnjit K. Khera, Owen Gethings, Ian Diamond, Ruth Studley, Nick P. Taylor, Tim Peto, A. Sarah Walker, Koen B. Pouwels, David W. Eyre, Emma Rourke, Tina Thomas, D. Pienaar, Joy Preece, Sarah Crofts, Lina Lloyd, Michelle Bowen, Daniel Ayoubkhani, Russell Black, Antonio Felton, Megan Crees, Joel W. Jones, Esther Sutherland, Derrick W. Crook, Emma Pritchard, Karina-Doris Vihta, Alison Howarth, Brian D. Marsden, Kevin Chau, Lucas Martins Ferreira, Wanwisa Dejnirattisai, Juthathip Mongkolsapaya, Sarah Hoosdally, Richard J. Cornall, David I. Stuart, Gavin Screaton, Katrina Lythgoe, David Bonsall, Tanya Golubchik, Helen Fryer, John Newton, John I. Bell, Stuart Cox, Kevin Paddon, Tim James, Thomas House, Julie V. Robotham, Paul Birrell, Helena Jordan, Tim Sheppard, Graham Athey, Dan Moody, Leigh Curry, Pamela Brereton, Ian Jarvis, Anna Godsmark, George Morris, Bobby Mallick, Phil Eeles, Jodie Hay, Harper VanSteenhouse, Jessica Lee, Sean White, Tim Evans, Lisa Bloemberg, Katie Allison, Anouska Pandya, Sophie Davis, David I. Conway, Margaret MacLeod, Chris CunninghamNature Communications 2024 · DOI

Abstract

SARS-CoV-2 reinfections increased substantially after Omicron variants emerged. Large-scale community-based comparisons across multiple Omicron waves of reinfection characteristics, risk factors, and protection afforded by previous infection and vaccination, are limited. Here we studied ~45,000 reinfections from the UK's national COVID-19 Infection Survey and quantified the risk of reinfection in multiple waves, including those driven by BA.1, BA.2, BA.4/5, and BQ.1/CH.1.1/XBB.1.5 variants. Reinfections were associated with lower viral load and lower percentages of self-reporting symptoms compared with first infections. Across multiple Omicron waves, estimated protection against reinfection was significantly higher in those previously infected with more recent than earlier variants, even at the same time from previous infection. Estimated protection against Omicron reinfections decreased over time from the most recent infection if this was the previous or penultimate variant (generally within the preceding year). Those 14-180 days after receiving their most recent vaccination had a lower risk of reinfection than those >180 days from their most recent vaccination. Reinfection risk was independently higher in those aged 30-45 years, and with either low or high viral load in their most recent previous infection. Overall, the risk of Omicron reinfection is high, but with lower severity than first infections; both viral evolution and waning immunity are independently associated with reinfection.

Introduction

Early in the pandemic, SARS-CoV-2 reinfections were rare, with previous infections providing 80–90% protection. The emergence of the Omicron variant fundamentally changed this landscape due to its high number of mutations and ability to escape existing immunity. Most existing studies on reinfection rely on national testing programs, which often over-represent symptomatic individuals and those with easy access to healthcare. This paper addresses the need for a large-scale, community-based comparison across multiple Omicron waves to quantify risk factors, the duration of protection from vaccination, and the impact of "variant-specific" immunity using unbiased longitudinal data.

Methodology and Data

The researchers utilized data from the UK’s National COVID-19 Infection Survey (CIS), a longitudinal study that performed regular swab tests on participants regardless of symptoms. The study followed approximately 535,000 participants between April 2020 and March 2023, analyzing roughly 11.3 million swab tests and identifying ~45,000 confirmed reinfections.

To analyze this dataset, the team employed flexible parametric survival models to estimate reinfection risk across five distinct Omicron waves (BA.1 through XBB.1.5). They also used robust linear regression to compare Cycle threshold (Ct) values—a proxy for viral load—and multinomial logistic regression to analyze differences in self-reported symptoms.

Key Findings

The "Variant Proximity" Effect and Waning Immunity

Protection against reinfection is determined by both the timing and the nature of previous exposure. Protection against a new Omicron subvariant was significantly higher if the previous infection was a recent Omicron relative rather than an older variant (like Delta or Alpha), even when adjusted for the time elapsed. However, protection from the most recent infection or vaccination significantly decreased after 180 days, reinforcing the role of "hybrid immunity" (infection + vaccination) in maintaining a defense against evolving subvariants.

Viral Load and Symptom Severity

Reinfections consistently showed higher Ct values (indicating lower viral loads) and a 40–50% lower likelihood of "classic" symptoms (fever, cough, loss of taste/smell) compared to first infections. The median Ct value was 23 for first infections, 25 for second, and 26 for third, indicating a statistically significant trend toward lower viral loads in subsequent infections.

Predicted mean Ct values (proxy for viral load) across different SARS-CoV-2 variants and infection sequences (1st, 2nd, 3rd infection), categorized by time since last vaccination.

Risk Factors

Reinfection risk was independently higher in adults aged 30–45. Interestingly, risk was also higher for those who had either a very low or very high viral load in their previous infection, suggesting that a weak initial immune response or a massive initial viral challenge might both predispose an individual to future reinfection.

Discussion

While reinfection is common in the Omicron era, it is generally characterized by lower severity than first infections. The study highlights that reinfection risk is driven by a combination of waning immunity and rapid viral evolution.

Limitations of the study include the potential for missed asymptomatic infections between monthly survey windows and the lack of direct data on clinical outcomes like hospitalizations or deaths. Future work is needed to monitor how hybrid immunity holds up against increasingly distant recombinant variants and to assess the long-term impact of repeated infections on population health.

Summary updated

Abstract

SARS-CoV-2 reinfections increased substantially after Omicron variants emerged. Large-scale community-based comparisons across multiple Omicron waves of reinfection characteristics, risk factors, and protection afforded by previous infection and vaccination, are limited. Here we studied ~45,000 reinfections from the UK's national COVID-19 Infection Survey and quantified the risk of reinfection in multiple waves, including those driven by BA.1, BA.2, BA.4/5, and BQ.1/CH.1.1/XBB.1.5 variants. Reinfections were associated with lower viral load and lower percentages of self-reporting symptoms compared with first infections. Across multiple Omicron waves, estimated protection against reinfection was significantly higher in those previously infected with more recent than earlier variants, even at the same time from previous infection. Estimated protection against Omicron reinfections decreased over time from the most recent infection if this was the previous or penultimate variant (generally within the preceding year). Those 14-180 days after receiving their most recent vaccination had a lower risk of reinfection than those >180 days from their most recent vaccination. Reinfection risk was independently higher in those aged 30-45 years, and with either low or high viral load in their most recent previous infection. Overall, the risk of Omicron reinfection is high, but with lower severity than first infections; both viral evolution and waning immunity are independently associated with reinfection.
BibTeX
@inproceedings{wei2024risk,
  author = {Jia Wei and Nicole Stoesser and Philippa C. Matthews and Tarnjit K. Khera and Owen Gethings and Ian Diamond and Ruth Studley and Nick P. Taylor and Tim Peto and A. Sarah Walker and Koen B. Pouwels and David W. Eyre and Emma Rourke and Tina Thomas and D. Pienaar and Joy Preece and Sarah Crofts and Lina Lloyd and Michelle Bowen and Daniel Ayoubkhani and Russell Black and Antonio Felton and Megan Crees and Joel W. Jones and Esther Sutherland and Derrick W. Crook and Emma Pritchard and Karina-Doris Vihta and Alison Howarth and Brian D. Marsden and Kevin Chau and Lucas Martins Ferreira and Wanwisa Dejnirattisai and Juthathip Mongkolsapaya and Sarah Hoosdally and Richard J. Cornall and David I. Stuart and Gavin Screaton and Katrina Lythgoe and David Bonsall and Tanya Golubchik and Helen Fryer and John Newton and John I. Bell and Stuart Cox and Kevin Paddon and Tim James and Thomas House and Julie V. Robotham and Paul Birrell and Helena Jordan and Tim Sheppard and Graham Athey and Dan Moody and Leigh Curry and Pamela Brereton and Ian Jarvis and Anna Godsmark and George Morris and Bobby Mallick and Phil Eeles and Jodie Hay and Harper VanSteenhouse and Jessica Lee and Sean White and Tim Evans and Lisa Bloemberg and Katie Allison and Anouska Pandya and Sophie Davis and David I. Conway and Margaret MacLeod and Chris Cunningham and Chris Cunningham},
  title = {{Risk of SARS-CoV-2 reinfection during multiple Omicron variant waves in the UK general population}},
  booktitle = {Nature Communications},
  year = {2024},
  doi = {10.1038/s41467-024-44973-1},
}
Figure